I agree that this site is using cookies. You can find further informations here.
X
Geirnaert, Marc
49  results:
Search for persons X
?
1

Application of Multi-Criteria Decision Analysis (MCDA) to P..:

Takhar, Pam ; Geirnaert, Marc ; Gavura, Scott...
Current Oncology.  31 (2024)  4 - p. 1876-1898 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Canada's First Joint Oncology-Allergy Clinic: Successful De..:

Robinson, Madeline ; Geirnaert, Marc ; Anderson, Brady.
Current Oncology.  30 (2023)  3 - p. 2862-2868 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Development of a Multi-Criteria Decision Analysis Rating To..:

Parmar, Ambica ; Dai, Wei Fang ; Dionne, Francois...
Current Oncology.  30 (2023)  4 - p. 3776-3786 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Clinical Outcomes in a Large Canadian Centralized CLL Clini..:

Yang, Jiayu ; Yang, Lin ; Tordon, Bryan...
Current Oncology.  30 (2023)  7 - p. 6411-6431 , 2023
Link: https://doi.org/10.3390/..
 
?
5

International society of oncology pharmacy practitioners (I..:

Walker, Andrew ; Chan, Alexandre ; Labra, Constanza Cortés...
Journal of Oncology Pharmacy Practice.  29 (2022)  5 - p. 1065-1074 , 2022
Link: https://doi.org/10.1177/..
 
?
6

Real world risk of infusion reactions and effectiveness of ..:

Bourrier, Nicole ; Landego, Ivan ; Bucher, Oliver...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
7

An overview of the role of selpercatinib and pralsetinib in..:

Nguyen, Vanessa Quang ; Geirnaert, Marc
Journal of Oncology Pharmacy Practice.  29 (2022)  2 - p. 450-456 , 2022
Link: https://doi.org/10.1177/..
 
?
8

Building a National Reassessment Process for Oncology Drugs..:

Dai, Wei ; Craig, Erica ; Fraser, Brent...
Current Oncology.  28 (2021)  6 - p. 4645-4654 , 2021
Link: https://doi.org/10.3390/..
 
?
9

Outpatient oral anticancer agent utilization and costs in M..:

Leong, Christine ; Czaykowski, Piotr ; Geirnaert, Marc...
Canadian Journal of Public Health.  112 (2021)  3 - p. 530-540 , 2021
Link: https://doi.org/10.17269..
 
?
10

Off-label infusion of biosimilar bevacizumab: A provincial ..:

Geirnaert, Marc ; Howarth, Jacy ; Kellett, Curtis...
Journal of Oncology Pharmacy Practice.  26 (2020)  7 - p. 1683-1685 , 2020
Link: https://doi.org/10.1177/..
 
?
11

A multicenter review of infusion-related reactions to darat..:

Geirnaert, Marc ; Howarth, Jacy ; Martin, Kristen...
Journal of Oncology Pharmacy Practice.  27 (2020)  4 - p. 907-910 , 2020
Link: https://doi.org/10.1177/..
 
?
12

Development of a Multi-Criteria Decision Analysis Rating To..:

Parmar, Ambica ; Dai, Wei Fang ; Dionne, Francois...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137247/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Canada's First Joint Oncology-Allergy Clinic: Successful De..:

Robinson, Madeline ; Geirnaert, Marc ; Anderson, Brady.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046925/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Real world risk of infusion reactions and effectiveness of ..:

Bourrier, Nicole ; Landego, Ivan ; Bucher, Oliver...
BMC Cancer. 2022 Feb 06;22(1):148.  , 2022
Link: http://hdl.handle.net/19..
 
?
15

Real world risk of infusion reactions and effectiveness of ..:

Bourrier, Nicole ; Landego, Ivan ; Bucher, Oliver...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818183/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15